Metacrine, Inc.
MTCRDelisted Mar 3, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001634379
Metacrine, Inc. was delisted on Mar 3, 2023; its insiders filed their last Form 4 on Mar 24, 2023; 29 institutions reported holding it in 13F filings for Q4 2022, worth $7.29M in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Metacrine, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 42 | 35 | −7 |
| Shares | 12.5M | 11.1M | −1.41M (−11.3%) |
| Value | $47.4M | $37.9M | −$9.47M (−20.0%) |
New holders (4)
Institutions that held Metacrine, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 48,099 | $165.0K | 0.00% |
| Belvedere Trading LLC | 29,267 | $102.0K | 0.03% |
| Group One Trading, L.P. | 18,523 | $64.0K | 0.00% |
| Prentice Wealth Management LLC | 750 | $3.00K | 0.00% |
Sold out (11)
Institutions that held Metacrine, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| FMR LLC | 312,500 | $1.19M |
| Parametric Portfolio Associates LLC | 55,753 | $212.0K |
| Ergoteles LLC | 29,900 | $114.0K |
| Virtu Financial LLC | 19,671 | $75.0K |
| Jacobs Levy Equity Management, Inc | 14,284 | $54.0K |
| M&T Bank Corp | 13,275 | $50.0K |
| Walleye Capital LLC | 11,787 | $45.0K |
| JPMorgan Chase & Co | 883 | $3.00K |
| Fifth Third Bancorp | 900 | $3.00K |
| New York State Common Retirement Fund | 40 | $0 |
| Citigroup Inc | 84 | $0 |